Browsing category:


The recent FDA approval for AstraZeneca’s Nexium 24 hour, or Esomeprazole, was exciting news for the pharmaceutical world. With over sixty million Americans suffering from heartburn at least once a month the advent of a 24 hour treatment that is easy to access is relieving. As an OTC or over the counter treatment for gastroesophageal[…]

Read More

Patients suffering from Gastroesophageal Reflux Disease (GERD), benefit greatly from esomeprazole. Also known as Prilosec I.V. in the United States, AstraZeneca will see their patent of this breakout drug expire in May of 2014. The International Foundation for Functional Gastrointestinal Disorders recently reported that health professionals from the American Gastroenterological Association estimate that 33 percent[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service